Diametric Capital »

Immix Biopharma shares owned by Diametric Capital

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $133k 15k 9.11

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Capital Management
Millennium Management
Adage Capital Partners GP
Logos Global Management
Vanguard Group
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
BlackRock
Geode Capital Management

View all funds holding Immix Biopharma